Literature DB >> 1692405

The stability, toxicity and effectiveness of unmodified and phosphorothioate antisense oligodeoxynucleotides in Xenopus oocytes and embryos.

T M Woolf1, C G Jennings, M Rebagliati, D A Melton.   

Abstract

The properties of antisense phosphorothioate and unmodified oligodeoxynucleotides have been studied in Xenopus oocytes and embryos. We find that phosphorothioates, like unmodified oligodeoxynucleotides, can degrade Vg1 mRNA in oocytes via an endogenous RNase H-like activity. In oocytes, phosphorothioate oligodeoxynucleotides are more stable than unmodified oligodeoxynucleotides and are more effective in degrading Vg1 mRNA. In embryos, neither unmodified nor phosphorothioate deoxyoligonucleotides were effective in degrading Vg1 message at sub-toxic doses.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1692405      PMCID: PMC330594          DOI: 10.1093/nar/18.7.1763

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  30 in total

1.  Selective elimination of mRNAs in vivo: complementary oligodeoxynucleotides promote RNA degradation by an RNase H-like activity.

Authors:  P Dash; I Lotan; M Knapp; E R Kandel; P Goelet
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

2.  RNase H cleavage of RNA hybridized to oligonucleotides containing methylphosphonate, phosphorothioate and phosphodiester bonds.

Authors:  P J Furdon; Z Dominski; R Kole
Journal:  Nucleic Acids Res       Date:  1989-11-25       Impact factor: 16.971

3.  Delivery of c-myc antisense phosphorothioate oligodeoxynucleotides to hematopoietic cells in culture by liposome fusion: specific reduction in c-myc protein expression correlates with inhibition of cell growth and DNA synthesis.

Authors:  S L Loke; C Stein; X Zhang; M Avigan; J Cohen; L M Neckers
Journal:  Curr Top Microbiol Immunol       Date:  1988       Impact factor: 4.291

4.  Injected anti-sense RNAs specifically block messenger RNA translation in vivo.

Authors:  D A Melton
Journal:  Proc Natl Acad Sci U S A       Date:  1985-01       Impact factor: 11.205

5.  Inhibition of Rous sarcoma virus replication and cell transformation by a specific oligodeoxynucleotide.

Authors:  P C Zamecnik; M L Stephenson
Journal:  Proc Natl Acad Sci U S A       Date:  1978-01       Impact factor: 11.205

6.  Comparative hybrid arrest by tandem antisense oligodeoxyribonucleotides or oligodeoxyribonucleoside methylphosphonates in a cell-free system.

Authors:  L J Maher; B J Dolnick
Journal:  Nucleic Acids Res       Date:  1988-04-25       Impact factor: 16.971

7.  Physicochemical properties of phosphorothioate oligodeoxynucleotides.

Authors:  C A Stein; C Subasinghe; K Shinozuka; J S Cohen
Journal:  Nucleic Acids Res       Date:  1988-04-25       Impact factor: 16.971

8.  Developmental expression of the protein product of Vg1, a localized maternal mRNA in the frog Xenopus laevis.

Authors:  L Dale; G Matthews; L Tabe; A Colman
Journal:  EMBO J       Date:  1989-04       Impact factor: 11.598

9.  Localized synthesis of the Vg1 protein during early Xenopus development.

Authors:  D Tannahill; D A Melton
Journal:  Development       Date:  1989-08       Impact factor: 6.868

10.  Developmental regulation of a gastrula-specific gene injected into fertilized Xenopus eggs.

Authors:  P A Krieg; D A Melton
Journal:  EMBO J       Date:  1985-12-16       Impact factor: 11.598

View more
  42 in total

1.  Modulation of human interferon-gamma biosynthesis by antisense oligodeoxynucleotides.

Authors:  C M Boeve; M De Ley
Journal:  Mol Biotechnol       Date:  2000-02       Impact factor: 2.695

2.  Increased specificity for antisense oligodeoxynucleotide targeting of RNA cleavage by RNase H using chimeric methylphosphonodiester/phosphodiester structures.

Authors:  R V Giles; D M Tidd
Journal:  Nucleic Acids Res       Date:  1992-02-25       Impact factor: 16.971

3.  Specificity of antisense oligonucleotides in vivo.

Authors:  T M Woolf; D A Melton; C G Jennings
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-15       Impact factor: 11.205

4.  Physical properties of oligonucleotides containing phosphoramidate-modified internucleoside linkages.

Authors:  J M Dagle; M E Andracki; R J DeVine; J A Walder
Journal:  Nucleic Acids Res       Date:  1991-04-25       Impact factor: 16.971

5.  Modified deoxyoligonucleotides stable to exonuclease degradation in serum.

Authors:  J P Shaw; K Kent; J Bird; J Fishback; B Froehler
Journal:  Nucleic Acids Res       Date:  1991-02-25       Impact factor: 16.971

6.  Targeted elimination of zygotic messages in Xenopus laevis embryos by modified oligonucleotides possessing terminal cationic linkages.

Authors:  J M Dagle; J L Littig; L B Sutherland; D L Weeks
Journal:  Nucleic Acids Res       Date:  2000-05-15       Impact factor: 16.971

7.  Stability and functional effectiveness of phosphorothioate modified duplex DNA and synthetic 'mini-genes'.

Authors:  S A Ciafrè; M Rinaldi; P Gasparini; D Seripa; L Bisceglia; L Zelante; M G Farace; V M Fazio
Journal:  Nucleic Acids Res       Date:  1995-10-25       Impact factor: 16.971

8.  Fertilization of Xenopus oocytes using the host transfer method.

Authors:  Patricia N Schneider; Alissa M Hulstrand; Douglas W Houston
Journal:  J Vis Exp       Date:  2010-11-02       Impact factor: 1.355

9.  A more efficient and specific strategy in the ablation of mRNA in Xenopus laevis using mixtures of antisense oligos.

Authors:  R Morgan; M Edge; A Colman
Journal:  Nucleic Acids Res       Date:  1993-09-25       Impact factor: 16.971

10.  Effects of phosphorothioate capping on antisense oligonucleotide stability, hybridization and antiviral efficacy versus herpes simplex virus infection.

Authors:  G D Hoke; K Draper; S M Freier; C Gonzalez; V B Driver; M C Zounes; D J Ecker
Journal:  Nucleic Acids Res       Date:  1991-10-25       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.